Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH - SWOT Analysis company profile is the essential source for top-level company data and information. Boehringer Ingelheim GmbH - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Boehringer Ingelheim (BI) is a global group of companies owned by the founding Boehringer family through the parent company, C. H. Boehringer Sohn AG & Co. KG. The group is engaged in the research, development, manufacture and marketing of branded and generic prescription drugs, consumer health care products, industrial chemicals, and animal health products. The group operates in Europe, the Americas, Asia, Australasia and Africa. BI is headquartered in Ingelheim, Germany and employed 41,354 people as of December 2009. The company recorded revenues* of E13,661 million ($19,052 million**) during the financial year (FY) ended December 2009, an increase of 10.6% over FY2008. The operating profit of the company was E2,239 million ($3,122.6 million**) during FY2009, an increase of 13.1% over FY2008. The net profit was E1,759 million ($2,453.2 million**) in FY2009, an increase of 23.5% over FY2008. * Revenues = Net sales + changes in inventories + other internal work performed and capitalized + other operating income. ** Calculated using the constant conversion rate of E1 = $1.39463 for the year ended December 31, 2009.
Scope of the Report
Boehringer Ingelheim (BI) is a global group of companies owned by the founding Boehringer family through the parent company, C. H. Boehringer Sohn AG & Co. KG. The group is engaged in the research, development, manufacture and marketing of branded and generic prescription drugs, consumer health care products, industrial chemicals, and animal health products. The group operates in Europe, the Americas, Asia, Australasia and Africa. BI is headquartered in Ingelheim, Germany and employed 41,354 people as of December 2009. The company recorded revenues* of E13,661 million ($19,052 million**) during the financial year (FY) ended December 2009, an increase of 10.6% over FY2008. The operating profit of the company was E2,239 million ($3,122.6 million**) during FY2009, an increase of 13.1% over FY2008. The net profit was E1,759 million ($2,453.2 million**) in FY2009, an increase of 23.5% over FY2008. * Revenues = Net sales + changes in inventories + other internal work performed and capitalized + other operating income. ** Calculated using the constant conversion rate of E1 = $1.39463 for the year ended December 31, 2009.
Scope of the Report
- Provides all the crucial information on Boehringer Ingelheim GmbH required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Boehringer Ingelheim GmbH in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Boehringer Ingelheim GmbH
- Data is supplemented with details on Boehringer Ingelheim GmbH history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Boehringer Ingelheim GmbH
- Support sales activities by understanding your customers’ businesses better
- Understand prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
Contents
SWOT COMPANY PROFILE: Boehringer Ingelheim GmbHKey Facts: Boehringer Ingelheim GmbH
Company Overview: Boehringer Ingelheim GmbH
Business Description: Boehringer Ingelheim GmbH
Company History: Boehringer Ingelheim GmbH
Key Employees: Boehringer Ingelheim GmbH
Key Employee Biographies: Boehringer Ingelheim GmbH
Products & Services Listing: Boehringer Ingelheim GmbH
Products & Services Analysis: Boehringer Ingelheim GmbH
SWOT analysis: Boehringer Ingelheim GmbH
- Strengths: Boehringer Ingelheim GmbH
- Weaknesses: Boehringer Ingelheim GmbH
- Opportunities: Boehringer Ingelheim GmbH
- Threats: Boehringer Ingelheim GmbH
Company View: Boehringer Ingelheim GmbH
Top Competitors: Boehringer Ingelheim GmbH
Location and Subsidiary: Boehringer Ingelheim GmbH
- Head Office: Boehringer Ingelheim GmbH
- Other Locations and Subsidiaries: Boehringer Ingelheim GmbH Skip to top